Industry › Clinical Trials

Press Releases

耀啟新程！康哲藥業今日於新加坡交易所主板實現二次上市

Jul 15, 2025 17:05 HKT/SGT

耀启新程！康哲药业今日于新加坡交易所主板实现二次上市

Jul 15, 2025 16:53 HKT/SGT

Silo Pharma Enters Letter of Intent for JV with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market

Jun 25, 2025 21:27 HKT/SGT

康哲藥業建議於新加坡交易所第二上市

Jun 25, 2025 18:13 HKT/SGT

康哲药业建议于新加坡交易所第二上市

Jun 25, 2025 17:24 HKT/SGT

Hua Medicine Announces at 2025 ADA Scientific Sessions that Dorzagliatin Combined with DPP-4 Inhibitor Shows Promise in Reducing Blood Lipids While Restoring Glucose Homeostasis

Jun 23, 2025 12:05 HKT/SGT

CanSinoBIO Launches Pneumococcal Vaccine: An Innovative Choice to Safeguard Children's Health

Jun 20, 2025 18:06 HKT/SGT

NEC and Chugai Pharmaceutical use AI to potentially enhance cancer treatment

Jun 18, 2025 12:40 HKT/SGT

Southeast Asian stem cell leader Medeze launches voluntary conditional cash partial offer for 10% stake in SGX-listed Cordlife Group Limited

May 14, 2025 15:00 HKT/SGT

HighTide Therapeutics to Showcase New Analyses of Phase 2 MASH/T2DM Studies of Berberine Ursodeoxycholate (HTD1801) and Pre-Clinical Results of Rimtoregtide (HTD4010) in Presentations at EASL Congress 2025

Apr 24, 2025 18:43 HKT/SGT

君圣泰医药三项创新研究成果即将亮相2025欧肝会(EASL)

Apr 24, 2025 18:35 HKT/SGT

熊去氧胆小檗碱（HTD1801）一药多效即将进入商业化新纪元

Apr 15, 2025 08:10 HKT/SGT

熊去氧膽小檗堿（HTD1801）一藥多效即將進入商業化新紀元

Apr 15, 2025 08:10 HKT/SGT

Berberine Ursodeoxycholate (HTD1801) Consistently Demonstrates Comprehensive Benefits for Patients with Type 2 Diabetes Mellitus, Approaching NDA

Apr 15, 2025 08:00 HKT/SGT

MASH疾病領域的大市場、大需求

Mar 20, 2025 11:53 HKT/SGT

MASH疾病领域的大市场、大需求

Mar 19, 2025 18:34 HKT/SGT

康哲藥業（00867）發佈2024年度業績：聚焦創新與專科突破重塑增長動能

Mar 19, 2025 18:19 HKT/SGT

康哲药业（00867）发布2024年度业绩：聚焦创新与专科突破重塑增长动能

Mar 19, 2025 18:06 HKT/SGT

重磅發佈 - 君聖泰醫藥在JAMA Network Open發表熊去氧膽小檗鹼治療2型糖尿病的臨床2期研究數據療效顯著多重代謝獲益市場前景廣闊

Mar 04, 2025 16:48 HKT/SGT

重磅发布 - 君圣泰医药在JAMA Network Open发表熊去氧胆小檗碱治疗2型糖尿病的临床2期研究数据疗效显著多重代谢获益市场前景广阔

Mar 04, 2025 12:32 HKT/SGT